Neuropace shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Neuropace (NPCE) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Neuropace by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $710k | 69k | 10.31 |
| 2025-06-30 | $767k | 69k | 11.14 |
| 2025-03-31 | $482k | 39k | 12.29 |
| 2024-12-31 | $409k | 37k | 11.19 |
| 2024-09-30 | $255k | 37k | 6.97 |
| 2024-06-30 | $276k | 37k | 7.56 |
| 2022-03-31 | $140k | 17k | 8.25 |
| 2021-12-31 | $176k | 17k | 10.09 |
| 2021-09-30 | $277k | 17k | 15.88 |
| 2021-06-30 | $416k | 17k | 23.84 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management